Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 DOVU DOVU +48.64%
#3 Akedo Akedo +46.30%
#4 Black Phoenix Black Phoenix +34.55%
#5 Velvet Velvet +32.25%
#6 DoubleZero DoubleZero +19.36%
#7 Cross Cross +16.34%
#8 Cap Cap +15.21%
#9 Tutorial Tutorial +13.37%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.43%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
PacificHealth Laboratories, Inc. PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLI
Rank in Stocks #39560
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing... PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
Share Price
$0.0001
Last synced: 2025-02-11
Market Cap
$438.31K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade PacificHealth Laboratories, Inc. (PHLI)

Category

Consumer Defensive
P/E ratio for PacificHealth Laboratories, Inc. (PHLI)
P/E ratio as of 2026 TTM: 0
According to PacificHealth Laboratories, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for PacificHealth Laboratories, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
The Procter & Gamble Company The Procter & Gamble Company
The Procter & Gamble Company
PG.US
 21.41 -
US
L'Oréal S.A. L'Oréal S.A.
L'Oréal S.A.
OR.PA
 32.48 -
FR
Colgate-Palmolive Company Colgate-Palmolive Company
Colgate-Palmolive Company
CL.US
 35.89 -
US
Hindustan Unilever Limited Hindustan Unilever Limited
Hindustan Unilever Limited
HINDUNILVR.NS
 33.01 -
IN
Henkel AG & Co. KGaA Henkel AG & Co. KGaA
Henkel AG & Co. KGaA
HEN.DE
 - -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.